Copenhagen Study of Obese Patients With Ischemic Heart Disease Undergoing Low Energy Diet or Interval Training (CUT-IT)
3. august 2014 oppdatert av: Eva Prescott
Copenhagen Study of Obese Patients With Ischemic Heart Disease Undergoing Low Energy Diet or Interval Training: A Randomized Clinical Trial
The purpose of the study is to make a head-to-head comparison of weight loss and interval training as methods of secondary prevention in overweight patients with ischemic heart disease.
Studieoversikt
Status
Fullført
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
In western countries 80 % of patients with ischemic heart disease (IHD) are overweight (BMI > 25). Weight loss using a low energy diet (LED, 800 - 1000 kcal/day) has been shown to induce a considerable weight loss in obese but otherwise healthy patients and to reduce the risk of cardiovascular disease and diabetes in these subjects. Additionally, a British study using a very low energy diet (VLED, 600 kcal/day) to obtain weight loss, has shown that subject with diagnosed type 2 diabetes had their blood glucose normalized after an 8 week VLED. However, the effect of LED has never been examined in overweight patients with IHD.
Several studies have shown that patients with IHD have a beneficial effect of exercise training regarding mortality and reduction in cardiovascular risk factors. A Norwegian group has shown that aerobic interval training results in the biggest increase in maximal oxygen uptake (VO2max). A high VO2max is correlated to decreased mortality in patients with IHD.
In conclusion, weight loss and exercise are known strategies in preventing progression of IHD and development of type 2 diabetes in these patients, however a head-to-head comparison of the two methods has never been made and it is unknown which intervention is the most effective in improving cardiovascular risk profile. Furthermore, several mechanisms behind the known beneficial effect of these interventions are unknown.
Studietype
Intervensjonell
Registrering (Faktiske)
70
Fase
- Ikke aktuelt
Kontakter og plasseringer
Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.
Studiesteder
-
-
-
Copenhagen, Danmark, 2400
- Bispebjerg Hospital
-
-
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
45 år til 75 år (Voksen, Eldre voksen)
Tar imot friske frivillige
Nei
Kjønn som er kvalifisert for studier
Alle
Beskrivelse
Inclusion Criteria:
- Stable Ischemic Heart Disease
- BMI 28 - 40 kg/m2
Exclusion criteria:
- Known Diabetes Mellitus
- Repeated Fasting plasma glucose ≥ 7 mmol/L or Hba1c > 7 %
- Severe or moderate valve disease
- Main stem stenosis
- Severe heart failure, Ejection Fraction < 35 %
- Physical or mental disability which are expected to prevent completion of intervention
- Severe Chronic obstructive Pulmonary Disease (COPD) (FEV1 < 50 % of expected) or asthma
- Active cancer
- Severe kidney (GFR < 40 ml/hour) or severe liver disease
- Severe ischemia or arrhythmias during exercise test
- 2. or 3. degree atrio-ventricular (AV) block, not protected by pacemaker
- Organised training more than 2 times a week prior to inclusion
- Significant weight loss or weight gain (> 5 %)3 month prior to inclusion
- Not able to comprehend written and oral informed consent
- Hormone treatment
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Forebygging
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Enkelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Weight Loss
12 weeks of Low Calorie Diet to obtain a 10 - 15 % weight loss.
Followed by 40 weeks on a weight maintenance diet and interval training 2 times a week.
|
Low calorie diet approx.
1000 kcal/day for 8 - 10 weeks to obtain a 10 - 15 % weight loss.
|
|
Eksperimentell: Interval Training
12 weeks of interval training 3 times a week followed by 40 weeks of interval training 2 times a week.
|
Interval training (IT) on an exercise bike 3 times a week, for the first 12 weeks, followed by 40 weeks of IT 2 times a week on exercise bike.
Each training session consists of active intervals with a total duration of 16 minutes (durations intervals between 1 and 4 minutes) at 90% of maximal heart rate.
Active intervals are separated by active pauses at 60% of maximal heart rate.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Change in Coronary Flow Reserve following the diet or training intervention and a maintenance period
Tidsramme: 0, 12 and 52 weeks
|
Assessed by a non-invasive echocardiographic Doppler measurement
|
0, 12 and 52 weeks
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Change in Heart Rate Variability and silent ischemia following the diet or training intervention and a maintenance period
Tidsramme: 0, 12 and 52 weeks
|
Assessed by Holter Monitoring for 24 - 48 hours
|
0, 12 and 52 weeks
|
|
Change in endothelial function following the diet or training intervention and a maintenance period
Tidsramme: 0, 12 and 52 weeks
|
Using the Endopat 2000 from Itamar
|
0, 12 and 52 weeks
|
|
Change in systolic and diastolic function following the diet or training intervention and a maintenance period
Tidsramme: 0, 12 and 52 weeks
|
Assessed by echocardiography resting and during physiological and medical stress.
|
0, 12 and 52 weeks
|
|
Change in body composition following the diet or training intervention and a maintenance period
Tidsramme: 0, 12 and 52 weeks
|
Assessed by anthropometry, dual X-ray absorptiometry (DXA) (lean body mass, percentage adipose tissue) and abdominal MRI (liver fat, muscle fat, subcutaneous fat and visceral fat at the level of L3).
|
0, 12 and 52 weeks
|
|
Change in myocardial blood flow following the diet or training intervention and a maintenance period
Tidsramme: 0, 12 and 52 weeks
|
Assessed by positron emission tomography of the heart
|
0, 12 and 52 weeks
|
|
Change in insulin action, beta cell function and incretin secretion following the diet or training intervention and a maintenance period
Tidsramme: 0, 12 and 52 weeks
|
A Oral Glucose Tolerance Test is performed.
|
0, 12 and 52 weeks
|
|
Change in oxidized lipids and lipoprotein particle size following the diet or training intervention and a maintenance period
Tidsramme: 0, 12 and 52 weeks
|
0, 12 and 52 weeks
|
|
|
Change in peak oxygen uptake (VO2max) following the diet or training intervention and a maintenance period
Tidsramme: 0, 12 and 52 weeks
|
Assessed using a bicycle ergometer
|
0, 12 and 52 weeks
|
|
Change in blood pressure following the diet or training intervention and a maintenance period
Tidsramme: 0, 12 and 52 weeks
|
0, 12 and 52 weeks
|
|
|
Change in inflammatory markers in urin, blood and adipose tissue following the diet or training intervention and a maintenance period
Tidsramme: 0, 12 and 52 weeks
|
0, 12 and 52 weeks
|
|
|
Change in quality of life following the diet or training intervention and a maintenance period
Tidsramme: 0, 12 and 52 weeks
|
0, 12 and 52 weeks
|
|
|
Change in ceramides, diacylglycerol og endocannabinoid (CB)-1 receptors in adipose tissue following the diet or training intervention and a maintenance period
Tidsramme: 0, 12 and 52 weeks
|
0, 12 and 52 weeks
|
|
|
Change in hormones derived from adipose tissue following the diet or training intervention and a maintenance period
Tidsramme: 0, 12 and 52 weeks
|
0, 12 and 52 weeks
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Sponsor
Samarbeidspartnere
Etterforskere
- Hovedetterforsker: Eva Prescott, MD, DMsc, Bispebjerg Hospital
Publikasjoner og nyttige lenker
Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.
Generelle publikasjoner
- Pedersen LR, Olsen RH, Frederiksen M, Astrup A, Chabanova E, Hasbak P, Holst JJ, Kjaer A, Newman JW, Walzem R, Wisloff U, Sajadieh A, Haugaard SB, Prescott E. Copenhagen study of overweight patients with coronary artery disease undergoing low energy diet or interval training: the randomized CUT-IT trial protocol. BMC Cardiovasc Disord. 2013 Nov 19;13:106. doi: 10.1186/1471-2261-13-106.
- Pedersen LR, Olsen RH, Jurs A, Astrup A, Chabanova E, Simonsen L, Wisloff U, Haugaard SB, Prescott E. A randomised trial comparing weight loss with aerobic exercise in overweight individuals with coronary artery disease: The CUT-IT trial. Eur J Prev Cardiol. 2015 Aug;22(8):1009-17. doi: 10.1177/2047487314545280. Epub 2014 Jul 31.
- Pedersen LR, Olsen RH, Anholm C, Astrup A, Eugen-Olsen J, Fenger M, Simonsen L, Walzem RL, Haugaard SB, Prescott E. Effects of 1 year of exercise training versus combined exercise training and weight loss on body composition, low-grade inflammation and lipids in overweight patients with coronary artery disease: a randomized trial. Cardiovasc Diabetol. 2019 Oct 1;18(1):127. doi: 10.1186/s12933-019-0934-x.
- Pedersen LR, Olsen RH, Anholm C, Walzem RL, Fenger M, Eugen-Olsen J, Haugaard SB, Prescott E. Weight loss is superior to exercise in improving the atherogenic lipid profile in a sedentary, overweight population with stable coronary artery disease: A randomized trial. Atherosclerosis. 2016 Mar;246:221-8. doi: 10.1016/j.atherosclerosis.2016.01.001. Epub 2016 Jan 13.
- Pedersen LR, Olsen RH, Jurs A, Anholm C, Fenger M, Haugaard SB, Prescott E. A randomized trial comparing the effect of weight loss and exercise training on insulin sensitivity and glucose metabolism in coronary artery disease. Metabolism. 2015 Oct;64(10):1298-307. doi: 10.1016/j.metabol.2015.07.007. Epub 2015 Jul 17.
- Olsen RH, Pedersen LR, Jurs A, Snoer M, Haugaard SB, Prescott E. A randomised trial comparing the effect of exercise training and weight loss on microvascular function in coronary artery disease. Int J Cardiol. 2015 Apr 15;185:229-35. doi: 10.1016/j.ijcard.2015.03.118. Epub 2015 Mar 11.
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart
1. september 2011
Primær fullføring (Faktiske)
1. april 2014
Studiet fullført (Faktiske)
1. april 2014
Datoer for studieregistrering
Først innsendt
26. oktober 2012
Først innsendt som oppfylte QC-kriteriene
7. november 2012
Først lagt ut (Anslag)
12. november 2012
Oppdateringer av studieposter
Sist oppdatering lagt ut (Anslag)
5. august 2014
Siste oppdatering sendt inn som oppfylte QC-kriteriene
3. august 2014
Sist bekreftet
1. august 2014
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- CUT-IT
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .